Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma

British Journal of Cancer

Volumn 111, Issue 12, 2014, Pages 2308-2315

  Yoshida, R ^a   Nakayama, H ^a   Nagata, M ^a   Hirosue, A ^a   Tanaka, T ^a   Kawahara, K ^a   Nakagawa, Y ^a   Matsuoka, Y ^a   Sakata, J ^a   Arita, H ^a   Hiraki, A ^a   Shinohara, M ^a   Ito, T ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

invasion; nucleostemin; oral squamous cell carcinoma (OSCC); prognosis; proliferation

Indexed keywords

FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSTEMIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; GNL3 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; ORAL SURGERY; PHENOTYPE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR INVASION; BIOSYNTHESIS; CELL PROLIFERATION; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; GTP-BINDING PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PHENOTYPE; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84927567369     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.539     Document Type: Article

References (33)

1. Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR (2013) Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288(25): 17954-17967.
2. Cada Z, Boucek J, Dvorankova B, Chovanec M, Plzak J, Kodets R, Betka J, Pinot GL, Gabius HJ, Smetana Jr. K (2007) Nucleostemin expression in squamous cell carcinoma of the head and neck. Anticancer Res 27(5A): 3279-3284.
3. Devarajan E, Huang S (2009) STAT3 as a central regulator of tumor metastases. Curr Mol Med 9(5): 626-633.
4. Fan Y, Liu Z, Zhao S, Lou F, Nilsson S, Ekman P, Xu D, Fang X (2006) Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Br J Cancer 94(11): 1658-1662.
5. Fukuda A, Wang SC, JPt Morris, Folias AE, Liou A, KimGE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, Hebrok M (2011) Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19(4): 441-455.
6. Gupta S, Kong W, Peng Y, Miao Q, Mackillop WJ (2009) Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States. Int J Cancer 125(9): 2159-2165.
7. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5): 646-674.
8. Huang S (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13(5): 1362-1366.
9. Laramore GE, Scott CB, Al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR, Schuller DE, Gahbauer RA, Schwade JG, Campbell BH (1992) Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23(4): 705-713.
10. Lin T, Meng L, Li Y, Tsai RY (2010) Tumor-initiating function of nucleostemin-enriched mammary tumor cells. Cancer Res 70(22): 9444-9452.
11. Lin T, Meng L, Lin TC, Wu LJ, Pederson T, Tsai RY (2014) Nucleostemin and GNL3L exercise distinct functions in genome protection and ribosome synthesis, respectively. J Cell Sci 127(Pt 10): 2302-2312.
12. Macha MA, Matta A, Kaur J, Chauhan SS, Thakar A, Shukla NK, Gupta SD, Ralhan R (2011) Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck 33(4): 482-489.
13. Matsumoto K, Horikoshi M, Rikimaru K, Enomoto S (1989) A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med 18(9): 498-501.
14. Meng L, Hsu JK, Zhu Q, Lin T, Tsai RY (2011) Nucleostemin inhibits TRF1 dimerization and shortens its dynamic association with the telomere. J Cell Sci 124(Pt 21): 3706-3714.
15. Meng L, Lin T, Peng G, Hsu JK, Lee S, Lin SY, Tsai RY (2013) Nucleostemin deletion reveals an essential mechanism that maintains the genomic stability of stem and progenitor cells. Proc Natl Acad Sci USA 110(28): 11415-11420.
16. Nakajima TE, Yoshida H, Okamoto N, Nagashima K, Taniguchi H, Yamada Y, Shimoda T, Masutomi K (2012) Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma. Cancer Sci 103(2): 233-238.
17. Neiva KG, Zhang Z, Miyazawa M, Warner KA, Karl E, Nor JE (2009) Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 11(6): 583-593.
18. Okamoto N, Yasukawa M, Nguyen C, Kasim V, Maida Y, Possemato R, Shibata T, Ligon KL, Fukami K, Hahn WC, Masutomi K (2011) Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. Proc Natl Acad Sci USA 108(51): 20388-20393.
19. Okumura K, Konishi A, Tanaka M, Kanazawa M, Kogawa K, Niitsu Y (1996) Establishment of high-and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J Cancer Res Clin Oncol 122(4): 243-248.
20. Platz H, Fries R, Hudec M (1985) Retrospective DOSAK Study on carcinomas of the oral cavity: results and consequences. J Maxillofac Surg 13(4): 147-153.
21. Qu J, Bishop JM (2012) Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency. J Cell Biol 197(6): 731-745.
22. Romanova L, Grand A, Zhang L, Rayner S, Katoku-Kikyo N, Kellner S, Kikyo N (2009) Critical role of nucleostemin in pre-rRNA processing. J Biol Chem 284(8): 4968-4977.
23. Shimosato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1(1): 19-35.
24. Shinriki S, Jono H, Ota K, Ueda M, Kudo M, Ota T, Oike Y, Endo M, IbusukiM, Hiraki A, Nakayama H, Yoshitake Y, Shinohara M, Ando Y (2009) Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Clin Cancer Res 15(17): 5426-5434.
25. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1): 10-29.
26. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676.
27. Tamase A, Muraguchi T, Naka K, Tanaka S, Kinoshita M, Hoshii T, Ohmura M, Shugo H, Ooshio T, Nakada M, Sawamoto K, Onodera M, Matsumoto K, Oshima M, Asano M, Saya H, Okano H, Suda T, Hamada J, Hirao A (2009) Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci USA 106(40): 17163-17168.
28. Tsai RY, McKay RD (2002) A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 16(23): 2991-3003.
29. Wang Z, Si X, Xu A, Meng X, Gao S, Qi Y, Zhu L, Li T, Li W, Dong L (2013) Activation of STAT3 in Human gastric cancer cells via interleukin (IL)-6-type cytokine signaling correlates with clinical implications. PLoS One 8(10): e75788.
30. Yamashita M, Nitta E, Nagamatsu G, Ikushima YM, Hosokawa K, Arai F, Suda T (2013) Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells. Biochem Biophys Res Commun 441(1): 196-201.
31. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R, Nagayama M (2001) Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37(1): 65-71.
32. Yoshida R, Fujimoto T, Kudoh S, Nagata M, Nakayama H, Shinohara M, Ito T (2011) Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells. Cancer Sci 102(7): 1418-1423.
33. Zhu Q, Yasumoto H, Tsai RY (2006) Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 26(24): 9279-9290.